pf-07248144
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Nov 16, 2020 (NCT04606446)
Timeline
Indications
Mechanism of action
- Histone acetyltransferase KAT6AINHIBITOR
KAT6A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07198035 | Phase 1 | Sep 18, 2025 | Pfizer |
| NCT07062965 | Phase 3 | Aug 5, 2025 | Pfizer |
| NCT07117799 | Phase 1 | Feb 4, 2025 | Pfizer |
| NCT04606446 | Phase 1 | Nov 16, 2020 | Pfizer |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 4 | 4 | 2 | 2020 |
1 organizations
Page 1 / 1